Retrospective Study of 82 Cases of Canine Lymphoma in Austria based on the Working Formulation and Immunophenotyping

Journal of Comparative Pathology

Volumn 136, Issue 2-3, 2007, Pages 186-192

  Guija de Arespacochaga, A ^a   Schwendenwein, I ^a   Weissenbock H ^b  

^a Central Laboratory   (Austria)

^b UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

dog; malignant lymphoma; non Hodgkin's lymphoma; tumour

Indexed keywords

B LYMPHOCYTE ANTIBODY; T LYMPHOCYTE ANTIBODY;

ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; AUSTRIA; B LYMPHOCYTE; CANCER CLASSIFICATION; CANCER STAGING; CONTROLLED STUDY; DOG DISEASE; FEMALE; FOLLICULAR LYMPHOMA; IMMUNOBLASTIC LYMPHOMA; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; INTERNATIONAL CLASSIFICATION OF DISEASES; LARGE CELL LYMPHOMA; LYMPHOCYTOMA; LYMPHOMA; MALE; MORPHOLOGY; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; T LYMPHOCYTE;

ANIMALS; AUSTRIA; B-LYMPHOCYTES; DOG DISEASES; DOGS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNOENZYME TECHNIQUES; IMMUNOPHENOTYPING; LYMPH NODES; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL; MALE; PREVALENCE; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

CANIS FAMILIARIS;

EID: 34047182539     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2007.01.009     Document Type: Article

References (27)

1. Appelbaum F.R., Sale G.E., Storb R., Charrier K., Deeg H.J., Graham T., and Wulff J.C. Phenotyping of canine lymphoma with monoclonal antibodies directed at cell surface antigens: classification, morphology, clinical presentation and response to chemotherapy. Hematological Oncology 2 (1984) 151-168
2. Carter R.F., Valli V.E.O., and Lumsden J.H. The cytology, histology and prevalence of cell types in canine lymphoma classified according to the National Cancer Institute Working Formulation. Canadian Journal of Veterinary Research 50 (1986) 154-164
3. Dobson J.M., Blackwood L.B., McInnes E.F., Bostock D., Nicholls P., Hoather T.M., and Tom B.D. Prognostic variables in canine multicentric lymphosarcoma. Journal of Small Animal Practice 42 (2001) 377-384
4. Dobson J.M., Samuel S., Milstein H., Rogers K., and Wood J.L.N. Canine neoplasia in the UK: estimates of incidence rates from a population of insured dogs. Journal of Small Animal Practice 43 (2002) 440-446
5. Ferrer L., Fondevila D., Rabanal R., Tarres J., and Ramis A. Immunohistochemical detection of CD3 antigen (pan T marker) in canine lymphomas. Journal of Veterinary Diagnostic Investigation 5 (1993) 616-620
6. Fisher S.G., and Fisher R.I. The epidemiology of non-Hodgkin's lymphoma. Oncogene 23 (2004) 6524-6534
7. Fournel-Fleury C., Magnol J., Bricaire P., Marchal T., Chabanne L., Delverdier A., Bryon P.A., and Felman P. Cytohistological and immunological classification of canine malignant lymphomas: comparison with human non-Hodgkin's lymphomas. Journal of Comparative Pathology 117 (1997) 35-59
8. Fournel-Fleury C., Ponce F., Felman F., Blavier A., Bonnefont C., Chabanne L., Marchal T., Cadore J.L., Goy-Thollot I., Ledieu D., Ghernati I., and Magnol J.P. Canine T-cell lymphomas: a morphological, immunological, and clinical study of 46 new cases. Veterinary Pathology 39 (2002) 92-109
9. Greenlee P.G., Filippa D.A., Quimby F.W., Patnaik A.K., Calvano S.E., Matus R.E., Kimmel M., Hurvitz A.I., and Lieberman P.H. Lymphomas in dogs. Cancer 66 (1990) 480-490
10. Groves F.D., Devesa S.S., Linet M.S., and Travis L.B. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995. Journal of the National Cancer Institute 92 (2000) 1240-1251
11. Hayes H.M., Tarone R.E., Cantor K.P., Jessen C.R., McCurnin D.M., and Richardson R.C. Case-control study of canine malignant lymphoma: positive association with dog owner's use of 2,4-dichlorophenoxyacetic acid herbicides. Journal of the National Cancer Institute 83 (1991) 1226-1231
12. Kiupel M., Teske E., and Bostock D. Prognostic factors for treated canine malignant lymphoma. Veterinary Pathology 36 (1999) 292-300
13. Lee Harris N., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K., Grogan T.M., Isaacson P.G., Knowles D.M., Mason D.Y., Müller-Hermelink H., Pileri S., Piris M.A., Ralfkiaer E., and Warnke R.A. A Revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 84 (1994) 1361-1392
14. MacEwen E.G., Hayes A.A., Matus R.E., and Kurzman I.D. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981). Journal of the American Veterinary Medical Association 190 (1987) 564-567
15. Messick, J. B. and Calderwood Mays, M. B. (2000). Classification of lymphomas. In: Schalm's Veterinary Hematology, 5th Edit., B. F. Feldman, J. G. Zinkl, N. C. Jain, Eds, Lippincott Williams & Wilkins, Philadelphia, pp. 604-613.
16. Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the international lymphoma study group classification of non-Hodgkin's lymphoma. Blood 89 (1997) 3909-3918
17. Non-Hodgkin's Lymphoma Pathologic Classification Project. National cancer institute sponsored study of classifications of non-Hodgkin's lymphomas. Cancer 49 (1982) 2112-2135
18. NLPCG (The Nationwide Lymphoma Pathology Cooperative Group). A retrospective histological study of 9,009 cases of malignant lymphoma in China using the NLPCG classification. Japanese Journal of Clinical Oncology 15 (1985) 645-651
19. Pilozzi E., Pulford K., Jones M., Müller-Hermelink H., Falini B., Ralfkiaer E., Pileri S., Pezzella F., De Wolf-Peeters C., Arber D., Stein H., Mason D., and Gatter K. Co-expression of CD79a (JCB117) and CD3 by lymphoblastic lymphoma. Journal of Pathology 186 (1988) 140-143
20. Ponce F., Magnol J., Ledieu D., Marchal T., Turinelli V., Chalvet-Monfray K., and Fournel-Fleury C. Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy. Veterinary Journal 167 (2004) 158-166
21. Proietti F.A., Carneiro-Proietti A.B.F., Catalan-Soares B.C., and Murphy E.L. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24 (2005) 6058-6068
22. Rosenberg M.P., Matus R.E., and Patnaik A.K. Prognostic factors in dogs with lymphoma and associated hypercalcemia. Journal of Veterinary Internal Medicine 5 (2005) 268-271
23. Teske E. Prognostic factors for malignant lymphoma in the dog: an update. Veterinary Quarterly 16 (1994) 29-31
24. Teske E. Canine malignant lymphoma: a review and comparison with human non-Hodgkin's lymphoma. Veterinary Quarterly 16 (1994) 209-219
25. Teske E., Wisman P., Moore P.F., and Van Heerde P. Histologic classification and immunophenotyping of canine non-Hodgkin's lymphomas: unexpected high frequency of T cell lymphomas with B cell morphology. Experimental Hematology 22 (1994) 1179-1187
26. Valli V.E., Jacobs R.M., Norris A., Couto C.G., Morrison W.B., McCaw D., Cotter S., Ogilvie G., and Moore A. The histologic classification of 602 cases of feline lymphoproliferative disease using the National Cancer Institute working formulation. Journal of Veterinary Diagnostic Investigation 12 (2000) 295-306
27. Wilkerson M.J., Dolce K., Koopman T., Shuman W., Chun R., Garrett L., Barber L., and Avery A. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules. Veterinary Immunology and Immunopathology 106 (2005) 179-196